Therapeutic Evaluation of Syrup Nexoliv™ for Liver Health Support
Background: Liver disorders, ranging from hepatitis to cirrhosis, are prevalent globally due to infections, toxins, and metabolic imbalances. Traditional medicine offers numerous herbal formulations known for their hepatoprotective properties. Syrup NexolivTM is a polyherbal formulation composed of 23 medicinal plants traditionally recognized for liver protection, detoxification, and overall hepatobiliary support. This study evaluates the hepatoprotective potential of Syrup Nexoliv (SN) based on its rich phytoconstituents. Objective: To assess the hepatoprotective effect of Syrup Nexoliv through its pharmacologically active ingredients, focusing on their synergistic roles in liver health. Methods: Syrup Nexoliv contains key hepatoprotective herbs such as Kalmegh (Andrographis paniculata), Kutki (Picrorhiza kurroa), Punarnava (Boerhavia diffusa), and Bhui Amla (Phyllanthus niruri), known for their anti-inflammatory, antioxidant, and detoxifying properties. The formulation was evaluated through literature-based evidence highlighting individual and combined therapeutic effects of its components on hepatic cells, liver enzymes, and oxidative stress parameters. Results: Phytochemical analysis of the ingredients revealed the presence of bioactive compounds such as andrographolides, picrosides, berberine, and glycyrrhizin, which exhibit hepatoprotective, anti-inflammatory, and antioxidant actions. These compounds help in stabilizing hepatic cell membranes, reducing elevated liver enzymes, enhancing bile secretion, and protecting against hepatotoxins. Herbal ingredients like Gilo (Tinospora cordifolia) and Mulethi (Glycyrrhiza glabra) further contribute to immune modulation and liver tissue regeneration. Collectively, these herbs demonstrate a synergistic effect in managing liver dysfunction and supporting hepatic detoxification processes. Conclusion: Syrup Nexoliv, with its comprehensive blend of hepatoprotective herbs, presents a promising natural therapeutic option for preventing and managing liver disorders. Further clinical studies are warranted to validate its efficacy and safety in liver disease patients, along with its potential role as an adjunct to conventional hepatoprotective therapies. Keywords: Liver disorders, herbal formulations, Syrup Nexoliv
Authors
- Raghavendara Kumar Sharma (ORCID: https://orcid.org/0000-0002-3935-3685)
- Md Anzar Alam (ORCID: https://orcid.org/0000-0002-3548-8873)
- Khalid Eqbal (ORCID: https://orcid.org/0000-0001-9690-7245)
- Arvind Kumar (ORCID: https://orcid.org/0000-0002-9695-4399)
- Barkati Md Tarique (ORCID: https://orcid.org/0000-0002-0937-4629)
- Mohd Aleemuddin Quamri (ORCID: https://orcid.org/0000-0002-2695-2582)
Institutions
- Jamia Hamdard (IN)
- All India Institute of Medical Sciences Jodhpur (IN)
- Z.V.M.Unani Medical College & Hospital (IN)
- All India Institute of Medical Sciences Bhopal (IN)
- Mahavir Cancer Institute and Research Centre (IN)
- Regional Research Institute of Unani Medicine (IN)
Publication Details
- Journal
- Journal of Drug Delivery and Therapeutics
- Published
- 2025-05-15
- DOI
- https://doi.org/10.22270/jddt.v15i5.7121
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00